-
1
-
-
0026084824
-
Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis
-
Davies SE, Portmann BC, O'Grady JG, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991;13:150-157
-
(1991)
Hepatology
, vol.13
, pp. 150-157
-
-
Davies, S.E.1
Portmann, B.C.2
O'Grady, J.G.3
-
2
-
-
0025777404
-
Orthotopic liver transplantation for patients with hepatitis B virus-related disease
-
Todo S, DeMetris AJ, Van Thiel D, et al. Orthotopic liver transplantation for patients with hepatitis B virus-related disease. Hepatology 1991;13:619-626
-
(1991)
Hepatology
, vol.13
, pp. 619-626
-
-
Todo, S.1
DeMetris, A.J.2
Van Thiel, D.3
-
3
-
-
0029898537
-
Inhibition of hepatitis B virus replication by targeted pretreatment of complexed antisense DNA in vitro
-
Nakazono K, Ito Y, Wu CH, Wu GY. Inhibition of hepatitis B virus replication by targeted pretreatment of complexed antisense DNA in vitro. Hepatology 1996;23:1297-1303
-
(1996)
Hepatology
, vol.23
, pp. 1297-1303
-
-
Nakazono, K.1
Ito, Y.2
Wu, C.H.3
Wu, G.Y.4
-
4
-
-
0030625870
-
Hepatitis B virus and liver transplantation: Concepts in antiviral prophylaxis
-
Grellier L, Dusheiko GM. Hepatitis B virus and liver transplantation: Concepts in antiviral prophylaxis. J Viral Hepatol 1997;4(Suppl 1):111-116
-
(1997)
J Viral Hepatol
, vol.4
, Issue.SUPPL. 1
, pp. 111-116
-
-
Grellier, L.1
Dusheiko, G.M.2
-
5
-
-
0029962626
-
Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin
-
Terrault NA, Zhou S, Combs C, et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin Hepatology 1996;24:1327-1333
-
(1996)
Hepatology
, vol.24
, pp. 1327-1333
-
-
Terrault, N.A.1
Zhou, S.2
Combs, C.3
-
6
-
-
0031410045
-
Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant
-
Tchervenkov JI, Tector AJ, Barkun JS, et al. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant. Ann Surg 1997;226:356-365
-
(1997)
Ann Surg
, vol.226
, pp. 356-365
-
-
Tchervenkov, J.I.1
Tector, A.J.2
Barkun, J.S.3
-
7
-
-
0031034330
-
Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation
-
Burbach GJ, Bienzel U, Neuhaus R, et al. Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation. Transplantation 1997;63:478-480
-
(1997)
Transplantation
, vol.63
, pp. 478-480
-
-
Burbach, G.J.1
Bienzel, U.2
Neuhaus, R.3
-
8
-
-
0029879163
-
Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization
-
McGory RW, Ishitani MB, Oliveira WM, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996;61:1358-1364
-
(1996)
Transplantation
, vol.61
, pp. 1358-1364
-
-
McGory, R.W.1
Ishitani, M.B.2
Oliveira, W.M.3
-
9
-
-
0029856065
-
Mercury poisoning associated with high-dose hepatitis B immune globulin administered alter liver transplantation for chronic hepatitis B
-
Lowell JA, Burgess S, Shenoy S, et al. Mercury poisoning associated with high-dose hepatitis B immune globulin administered alter liver transplantation for chronic hepatitis B. Liver Transplant Surg 1996;2:475-478
-
(1996)
Liver Transplant Surg
, vol.2
, pp. 475-478
-
-
Lowell, J.A.1
Burgess, S.2
Shenoy, S.3
-
10
-
-
0343406745
-
Hepatitis B virus mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis
-
Ghary MG, Ayola B, Villamil FG, et al. Hepatitis B virus mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998;27: 213-222
-
(1998)
Hepatology
, vol.27
, pp. 213-222
-
-
Ghary, M.G.1
Ayola, B.2
Villamil, F.G.3
-
11
-
-
0031983151
-
Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation
-
Protzer-Knolle U, Naumann U, Bartenschlager R, et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 1998;27:254-263
-
(1998)
Hepatology
, vol.27
, pp. 254-263
-
-
Protzer-Knolle, U.1
Naumann, U.2
Bartenschlager, R.3
-
12
-
-
1842291578
-
The treatment of chronic viral hepatitis
-
Hoofnagle JH, Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-356
-
(1997)
N Engl J Med
, vol.336
, pp. 347-356
-
-
Hoofnagle, J.H.1
Bisceglie, A.M.2
-
13
-
-
0029932608
-
Interferon alfa for recurrent hepatitis B infection after liver transplantation
-
Terrault NA, Holland CC, Ferrell L, et al. Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transplant Surg 1996;2:132-138
-
(1996)
Liver Transplant Surg
, vol.2
, pp. 132-138
-
-
Terrault, N.A.1
Holland, C.C.2
Ferrell, L.3
-
14
-
-
0028968065
-
Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression
-
Gish RG, Keefe EB, Lim J, et al. Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression. Hepatology 1995;22:257-262
-
(1995)
Hepatology
, vol.22
, pp. 257-262
-
-
Gish, R.G.1
Keefe, E.B.2
Lim, J.3
-
15
-
-
0025787396
-
Liver transplantation in HBs antigen (HbsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization
-
Muller R, Gubernais G, Farle M, et al. Liver transplantation in HBs antigen (HbsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. Hepatology 1991;13:90-96
-
(1991)
Hepatology
, vol.13
, pp. 90-96
-
-
Muller, R.1
Gubernais, G.2
Farle, M.3
-
16
-
-
0030448498
-
Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIG) prophylaxis after liver transplantation
-
Nymann T, Shokouh-Amiri MH, Vera SR, et al. Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIG) prophylaxis after liver transplantation. Clin Transplant 1996;10:663-667
-
(1996)
Clin Transplant
, vol.10
, pp. 663-667
-
-
Nymann, T.1
Shokouh-Amiri, M.H.2
Vera, S.R.3
-
17
-
-
16044367618
-
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis
-
Grellier L, Mutimer D, Ahmed M, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996;348:1212-1215
-
(1996)
Lancet
, vol.348
, pp. 1212-1215
-
-
Grellier, L.1
Mutimer, D.2
Ahmed, M.3
-
18
-
-
0000209664
-
Lamivudine for suppression and/or prevention of hepatitis B when given pre/post liver transplantation (OLT)
-
Perrillo R, Rakela J, Martin P, et al. Lamivudine for suppression and/or prevention of hepatitis B when given pre/post liver transplantation (OLT) [abstract]. Hepatology 1997;26:260a
-
(1997)
Hepatology
, vol.26
-
-
Perrillo, R.1
Rakela, J.2
Martin, P.3
-
19
-
-
0000252517
-
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin
-
Markowitz JS, Martin P, Conrad AJ. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin [abstract]. Hepatology 1997;26:152a
-
(1997)
Hepatology
, vol.26
-
-
Markowitz, J.S.1
Martin, P.2
Conrad, A.J.3
-
20
-
-
0029683119
-
Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: A pilot study
-
Kruger M, Tillman HL, Trautwein C, et al. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: A pilot study. Liver Transplant Surg 1996;2:253-262
-
(1996)
Liver Transplant Surg
, vol.2
, pp. 253-262
-
-
Kruger, M.1
Tillman, H.L.2
Trautwein, C.3
-
21
-
-
0000571381
-
Long term lamivudine therapy of patients with recurrent hepatitis B post liver transplantation
-
Perrillo R, Rakela J, Martin P, et al. Long term lamivudine therapy of patients with recurrent hepatitis B post liver transplantation [abstract]. Hepatology 1997;26:177a
-
(1997)
Hepatology
, vol.26
-
-
Perrillo, R.1
Rakela, J.2
Martin, P.3
-
22
-
-
0030061482
-
Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients
-
Gish RG, Lau JYN, Brooks L, et al. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996;23:1-7
-
(1996)
Hepatology
, vol.23
, pp. 1-7
-
-
Gish, R.G.1
Lau, J.Y.N.2
Brooks, L.3
-
23
-
-
0000209665
-
Management and outcome of lamivudine (LAM) resistant hepatitis B virus (HBV) infection after liver transplantation
-
Shields PL, Ling R, Harrison T, et al. Management and outcome of lamivudine (LAM) resistant hepatitis B virus (HBV) infection after liver transplantation [abstract]. Hepatology 1997;26:260a
-
(1997)
Hepatology
, vol.26
-
-
Shields, P.L.1
Ling, R.2
Harrison, T.3
-
24
-
-
0028236954
-
Prostaglandin E plus famciclovir-a now concept for the treatment of severe hepatitis B after liver transplantation
-
Boker KH, Ringe B, Kruger M, et al. Prostaglandin E plus famciclovir-a now concept for the treatment of severe hepatitis B after liver transplantation. Transplantation 1994;57:1706-1708
-
(1994)
Transplantation
, vol.57
, pp. 1706-1708
-
-
Boker, K.H.1
Ringe, B.2
Kruger, M.3
-
25
-
-
0001228985
-
Safety and efficacy of famciclovir for the treatment of recurrent hepatitis B in liver transplant recipients
-
Neuhaus P, Manns MP, Atkinson G. Safety and efficacy of famciclovir for the treatment of recurrent hepatitis B in liver transplant recipients [abstract]. Hepatology 1997;26:260a
-
(1997)
Hepatology
, vol.26
-
-
Neuhaus, P.1
Manns, M.P.2
Atkinson, G.3
-
26
-
-
0000486639
-
Prolonged therapy of recurrent hepatitis B infection after liver transplantation with nucleoside analogues
-
Jaeckel E, Tillmann HL, Kruger M, et al. Prolonged therapy of recurrent hepatitis B infection after liver transplantation with nucleoside analogues [abstract]. J Hepatol 1998;28(suppl):115a
-
(1998)
J Hepatol
, vol.28
, Issue.SUPPL.
-
-
Jaeckel, E.1
Tillmann, H.L.2
Kruger, M.3
-
27
-
-
0019813866
-
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
-
Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-435
-
(1981)
Hepatology
, vol.1
, pp. 431-435
-
-
Knodell, R.G.1
Ishak, K.G.2
Black, W.C.3
-
28
-
-
0001242734
-
Hepatitis B virus polymerase mutations during famciclovir therapy in patients following liver transplantation
-
Aye TT, Bartholomeusz AI, Shaw T, et al. Hepatitis B virus polymerase mutations during famciclovir therapy in patients following liver transplantation [abstract]. Hepatitis 1996;24:285a
-
(1996)
Hepatitis
, vol.24
-
-
Aye, T.T.1
Bartholomeusz, A.I.2
Shaw, T.3
-
29
-
-
0030905343
-
Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation
-
Aye TT, Bartholomeusz AI, Shaw T, et al. Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. J Hepatol 1997;26:1148-1153
-
(1997)
J Hepatol
, vol.26
, pp. 1148-1153
-
-
Aye, T.T.1
Bartholomeusz, A.I.2
Shaw, T.3
-
30
-
-
0029817898
-
Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo
-
Tipples GA, Ma MM, Fischer KP, et al. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996;24:714-717
-
(1996)
Hepatology
, vol.24
, pp. 714-717
-
-
Tipples, G.A.1
Ma, M.M.2
Fischer, K.P.3
-
31
-
-
0009218685
-
Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
-
Bartholomew MM, Jansen RW, Jeffers LH, et al. Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1996;348:1212-1215
-
(1996)
Lancet
, vol.348
, pp. 1212-1215
-
-
Bartholomew, M.M.1
Jansen, R.W.2
Jeffers, L.H.3
-
32
-
-
0001674626
-
Famciclovir treatment in lamivudine resistant chronic hepatitis B patients
-
Wolters LMM, Honkoop P, de Man RA, et al. Famciclovir treatment in lamivudine resistant chronic hepatitis B patients [abstract]. J Hepatol 1998;28(Suppl 1):113a
-
(1998)
J Hepatol
, vol.28
, Issue.SUPPL. 1
-
-
Wolters, L.M.M.1
Honkoop, P.2
De Man, R.A.3
-
33
-
-
0008384291
-
Response and mutations in patients sequentially treated with lamivudine and famciclovir for recurrent hepatitis B after liver transplantation
-
Tillmann HL, Trautwein C, Bock T, et al. Response and mutations in patients sequentially treated with lamivudine and famciclovir for recurrent hepatitis B after liver transplantation [abstract]. Hepatology 1997;26:429a
-
(1997)
Hepatology
, vol.26
-
-
Tillmann, H.L.1
Trautwein, C.2
Bock, T.3
-
34
-
-
0031938029
-
Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective
-
Melegari M, Scaglioni PP, Wands JR. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology 1997;27:628-633
-
(1997)
Hepatology
, vol.27
, pp. 628-633
-
-
Melegari, M.1
Scaglioni, P.P.2
Wands, J.R.3
-
35
-
-
0030926706
-
Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro
-
Colledge D, Locarnini S, Shaw T. Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro. Hepatology 1997;26:216-225
-
(1997)
Hepatology
, vol.26
, pp. 216-225
-
-
Colledge, D.1
Locarnini, S.2
Shaw, T.3
-
37
-
-
0000076031
-
Lack of cross resistance to PMEA for human hepatitis B DNA polymerases which express lamivudine resistance codons
-
Xioing X, Flores C, Gibbs C, et al. Lack of cross resistance to PMEA for human hepatitis B DNA polymerases which express lamivudine resistance codons [abstract]. Hepalology 1997; 26:431a
-
(1997)
Hepalology
, vol.26
-
-
Xioing, X.1
Flores, C.2
Gibbs, C.3
|